BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32446859)

  • 1. Long non-coding RNA HAGLROS regulates lipid metabolism reprogramming in intrahepatic cholangiocarcinoma via the mTOR signaling pathway.
    Ma J; Feng J; Zhou X
    Exp Mol Pathol; 2020 Aug; 115():104466. PubMed ID: 32446859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in colorectal cancer cells via sponging miR-100 to target ATG5 expression.
    Zheng Y; Tan K; Huang H
    J Cell Biochem; 2019 Mar; 120(3):3922-3933. PubMed ID: 30430634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
    Zhang W; Zhang Y; Xi S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
    Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
    Wei H; Hu J; Pu J; Tang Q; Li W; Ma R; Xu Z; Tan C; Yao T; Wu X; Long X; Wang J
    Int Immunopharmacol; 2019 Aug; 73():72-80. PubMed ID: 31082725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
    Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
    Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HAGLROS promotes the process of mantle cell lymphoma by regulating miR-100/ATG5 axis and involving in PI3K/AKT/mTOR signal.
    Mu G; Liu Q; Wu S; Xia Y; Fang Q
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3649-3656. PubMed ID: 31498006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer.
    Yang M; Zhai Z; Zhang Y; Wang Y
    Arch Gynecol Obstet; 2019 Sep; 300(3):703-710. PubMed ID: 31197441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA HAGLROS regulates cell apoptosis and autophagy in lipopolysaccharides-induced WI-38 cells via modulating miR-100/NF-κB axis.
    Liu M; Han T; Shi S; Chen E
    Biochem Biophys Res Commun; 2018 Jun; 500(3):589-596. PubMed ID: 29673591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma.
    Sun Q; Gong X; Wu J; Hu Z; Zhang Q; Gong J; Zhu X
    Biomed Res Int; 2021; 2021():8893652. PubMed ID: 34337058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
    Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordycepin reprogramming lipid metabolism to block metastasis and EMT via ERO1A/mTOR/SREBP1 axis in cholangiocarcinoma.
    Zhou X; Li Y; Yang C; Chen D; Wang T; Liu T; Yan W; Su Z; Peng B; Ren X
    Life Sci; 2023 Aug; 327():121698. PubMed ID: 37080351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSPB8 promoted intrahepatic cholangiocarcinoma progression by enhancing epithelial-mesenchymal transition and autophagy.
    Shu B; Zhou Y; Liang Q; He C; Li F
    Exp Mol Pathol; 2021 Dec; 123():104691. PubMed ID: 34606781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.
    Li F; Chen Q; Xue H; Zhang L; Wang K; Shen F
    Cell Death Dis; 2020 Oct; 11(10):894. PubMed ID: 33093444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co‑expression of the carbamoyl‑phosphate synthase 1 gene and its long non‑coding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma.
    Ma SL; Li AJ; Hu ZY; Shang FS; Wu MC
    Mol Med Rep; 2015 Dec; 12(6):7915-26. PubMed ID: 26499888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-coding RNA CASC15 Promotes Intrahepatic Cholangiocarcinoma Possibly through Inducing PRDX2/PI3K/AKT Axis.
    Zhang Y; Zhang L; Lu S; Xiang Y; Zeng C; He T; Ding Y; Wang W
    Cancer Res Treat; 2021 Jan; 53(1):184-198. PubMed ID: 33017884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.